Glycogen storage disease type III: research gaining momentum
Research into glycogen storage disease type III is gaining momentum, with advances across many areas and active contributions from Généthon and I-Stem.

Welcome to AFM-Telethon's website

Research into glycogen storage disease type III is gaining momentum, with advances across many areas and active contributions from Généthon and I-Stem.

A new design, enriched content, simpler, smoother and more intuitive navigation, and an innovative AI-powered search engine… The Institute of Myology has completely redesigned its website to provide users with a more seamless and effective browsing experience. The new site makes the expertise and knowledge of this centre dedicated to muscle and muscle diseases more accessible than ever.

The 9th international congress dedicated to muscle biology and neuromuscular diseases, MYOLOGY 2027, will take place in Strasbourg, France, from May 10 to 13, 2027. Registration and abstract submissions are now open on the dedicated website.

Discover Cure Through Innovation 2026, the reference brochure presenting at a glance the core missions, commitments, and achievements of AFM-Téléthon. An essential document to grasp the diversity of its actions and the emergence of an innovative medicine born from 66 years of fighting.
The French Muscular Dystrophy Association (AFM-Téléthon) is a patient-led organisation driving research and support for people with rare genetic diseases. From groundbreaking therapies to daily care, discover how AFM-Téléthon turns innovation into hope.
You live abroad and want to be part of the great Telethon adventure? Join us!